Two Sigma Advisers’s Aravive ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-19,948
Closed -$25.1K – 2630
2023
Q2
$25.1K Sell
19,948
-140,667
-88% -$228K ﹤0.01% 2316
2023
Q1
$321K Buy
160,615
+66,400
+70% +$125K ﹤0.01% 2111
2022
Q4
$124K Buy
94,215
+51,100
+119% +$65.2K ﹤0.01% 2271
2022
Q3
$35K Sell
43,115
-35,333
-45% -$30.4K ﹤0.01% 2401
2022
Q2
$77K Sell
78,448
-18,400
-19% -$24.3K ﹤0.01% 2424
2022
Q1
$187K Sell
96,848
-55,200
-36% -$119K ﹤0.01% 2397
2021
Q4
$333K Sell
152,048
-29,328
-16% -$97.5K ﹤0.01% 2106
2021
Q3
$675K Sell
181,376
-115,900
-39% -$495K ﹤0.01% 1794
2021
Q2
$1.78M Buy
297,276
+33,300
+13% +$176K ﹤0.01% 1346
2021
Q1
$1.74M Buy
263,976
+46,900
+22% +$308K ﹤0.01% 1339
2020
Q4
$1.22M Sell
217,076
-11,600
-5% -$63.7K ﹤0.01% 1474
2020
Q3
$1.08M Buy
228,676
+73,913
+48% +$525K ﹤0.01% 1477
2020
Q2
$1.8M Sell
154,763
-5,562
-3% -$66K 0.01% 1255
2020
Q1
$923K Buy
160,325
+82,462
+106% +$738K ﹤0.01% 1528
2019
Q4
$1.06M Buy
77,863
+61,567
+378% +$544K ﹤0.01% 1548
2019
Q3
$122K Sell
16,296
-800
-5% -$4.99K ﹤0.01% 2097
2019
Q2
$103K Sell
17,096
-4,700
-22% -$29.3K ﹤0.01% 2213
2019
Q1
$153K Sell
21,796
-2,800
-11% -$14.6K ﹤0.01% 2153
2018
Q4
$87K Buy
24,596
+113
+0.5% +$650 ﹤0.01% 2231
2018
Q3
$206K Sell
24,483
-2,150
-8% -$22.7K ﹤0.01% 2073
2018
Q2
$324K Sell
26,633
-217
-0.8% -$2.24K ﹤0.01% 2076
2018
Q1
$266K Buy
26,850
+900
+3% +$10.1K ﹤0.01% 2057
2017
Q4
$343K Buy
25,950
+10,117
+64% +$130K ﹤0.01% 1900
2017
Q3
$233K Buy
+15,833
New +$1.6M ﹤0.01% 2009
2017
Q2
– Sell
-3,183
Closed -$408K – 2442
2017
Q1
$408K Buy
+3,183
New +$336K ﹤0.01% 1974

Other funds holding ARAV

Two Sigma Advisers's ARAV Position: Q3 2023 in Review

Two Sigma Advisers sold out of Aravive (ARAV) in Q3 2023, closing a stake of 19,948 shares — an estimated $25.1K sold.

Two Sigma Advisers first reported a position in ARAV in Q1 2017 and held it in 25 quarters. The position peaked at $1.8M in Q2 2020. 33 funds tracked by Wall St. Rank hold ARAV as of Q3 2023.

  • Two Sigma Advisers reported no remaining Aravive position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 19,948 Aravive shares in Q3 2023, an estimated $25.1K.
  • Two Sigma Advisers first reported a position in Aravive in Q1 2017 and held it in 25 quarters.
  • Two Sigma Advisers's Aravive position peaked at $1.8M in Q2 2020.
  • 33 funds tracked by Wall St. Rank held Aravive as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.